Detalhe da pesquisa
1.
Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.
Circulation
; 137(11): 1117-1129, 2018 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29101289
2.
Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation.
Am Heart J
; 173: 77-85, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26920599
3.
Optimal antithrombotic treatment in patients with atrial fibrillation and coronary stents: an update.
Curr Opin Cardiol
; 31(4): 356-65, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27205887
4.
Triple therapy for atrial fibrillation and percutaneous coronary intervention.
Curr Opin Cardiol
; 30(6): 690-6, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26406301
5.
Response by de Veer et al to Letter Regarding Article, "Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials".
Circulation
; 138(12): 1279, 2018 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30354436
6.
Dual versus triple antithrombotic therapy after percutaneous coronary intervention: the prospective multicentre WOEST 2 Study.
EuroIntervention
; 18(4): e303-e313, 2022 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35370126
7.
Economic evaluation of the use of non-vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: a modelling analysis using the healthcare system in the Netherlands.
Eur Heart J Qual Care Clin Outcomes
; 5(2): 127-135, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30016398
8.
Antithrombotic treatment in patients undergoing transcatheter aortic valve implantation (TAVI).
Thromb Haemost
; 113(4): 674-85, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25653053